Bart Lutterbach
- Hematology top 1%
- Acute Myeloid Leukemia Research 11
- Aging top 5%
- Molecular Biology top 5%
- Protein Kinase Regulation and GTPase Signaling 5
- Retinoids in leukemia and cellular processes 5
- Protein Degradation and Inhibitors 4
- Ubiquitin and proteasome pathways 4
- Histone Deacetylase Inhibitors Research 4
- Genomics and Chromatin Dynamics 4
- Oncology top 5%
- Hepatology top 5%
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Scott W. HiebertStephan HannBryan LinggiLenora J. DavisJennifer J. WestendorfJoseph M. AmannEdward SetoHarold Hatch
- Cited by
- HematologyAgingMolecular Biology
- Partner nations
- United StatesJapanMalaysia
In The Last Decade
Bart Lutterbach
29 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 91
- Hematology 1.0k
- Aging 79
- Molecular Biology 2.5k
- Oncology 653
- Hepatology 175
Countries citing papers authored by Bart Lutterbach
This map shows the geographic impact of Bart Lutterbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Lutterbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Lutterbach more than expected).
Fields of papers citing papers by Bart Lutterbach
This network shows the impact of papers produced by Bart Lutterbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Lutterbach. The network helps show where Bart Lutterbach may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bart Lutterbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 33 | |
| 2 | 2010 | 139 | |
| 3 | Abstract #3714: In vitro and in vivo antitumor activities of MK-2206, a new allosteric Akt inhibitor | 2009 | 11 |
| 4 | 2008 | 230 | |
| 5 | 2008 | 11 | |
| 6 | 2007 | 260 | |
| 7 | 2006 | 60 | |
| 8 | 2002 | 51 | |
| 9 | 2001 | 44 | |
| 10 | 2001 | 270 | |
| 11 | 2001 | 23 | |
| 12 | 2000 | 170 | |
| 13 | 2000 | 16 | |
| 14 | 2000 | 91 | |
| 15 | 1999 | 18 | |
| 16 | 1998 | 156 | |
| 17 | 1997 | 29 | |
| 18 | 1995 | 123 | |
| 19 | 1994 | 77 | |
| 20 | 1991 | 97 |
About Bart Lutterbach
Bart Lutterbach is a scholar working on Hematology, Aging and Molecular Biology, having authored 29 papers that have together received 3.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Retinoids in leukemia and cellular processes (5 papers), Protein Degradation and Inhibitors (4 papers), Ubiquitin and proteasome pathways (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Genomics and Chromatin Dynamics (4 papers). The work is most often cited by research in Hematology (1.0k citations), Aging (79 citations) and Molecular Biology (2.5k citations). Bart Lutterbach has collaborated with scholars based in United States, Japan and Malaysia. Frequent co-authors include Scott W. Hiebert, Stephan Hann, Bryan Linggi, Lenora J. Davis, Jennifer J. Westendorf, Joseph M. Amann, Edward Seto, Harold Hatch, James R. Downing and John Nip. Their work appears in journals such as Molecular and Cellular Biology, Cancer Research, Oncogene, Journal of Biological Chemistry and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.